Literature DB >> 25447835

Prostate cancer: Identifying sites of recurrence with choline-PET-CT imaging.

Paolo Castellucci1, Stefano Fanti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25447835     DOI： 10.1038/nrurol.2014.321

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer.

Authors:  Jan D Soyka; Marco A Muster; Daniel T Schmid; Burkhardt Seifert; Ulrike Schick; Raymond Miralbell; Sandra Jorcano; Kathrin Zaugg; Hans-Helge Seifert; Patrick Veit-Haibach; Klaus Strobel; Niklaus G Schaefer; Daniela B Husarik; Thomas F Hany
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03-14       Impact factor: 9.236

2.  Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?

Authors:  Jeffrey Goldstein; Einat Even-Sapir; Simona Ben-Haim; Akram Saad; Benjamin Spieler; Tima Davidson; Raanan Berger; Ilana Weiss; Sarit Appel; Yaacov R Lawrence; Zvi Symon
Journal:  Am J Clin Oncol       Date:  2017-06       Impact factor: 2.339

3.  Prostate cancer, version 1.2014.

Authors:  James L Mohler; Philip W Kantoff; Andrew J Armstrong; Robert R Bahnson; Michael Cohen; Anthony Victor D'Amico; James A Eastham; Charles A Enke; Thomas A Farrington; Celestia S Higano; Eric Mark Horwitz; Mark H Kawachi; Michael Kuettel; Richard J Lee; Gary R Macvicar; Arnold W Malcolm; David Miller; Elizabeth R Plimack; Julio M Pow-Sang; Sylvia Richey; Mack Roach; Eric Rohren; Stan Rosenfeld; Eric J Small; Sandy Srinivas; Cy Stein; Seth A Strope; Jonathan Tward; Patrick C Walsh; Dorothy A Shead; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-12-01       Impact factor: 11.908

4.  Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial.

Authors:  Francesco Ceci; Ken Herrmann; Paolo Castellucci; Tiziano Graziani; Christina Bluemel; Riccardo Schiavina; Christian Vollmer; Sabine Droll; Eugenio Brunocilla; Renzo Mazzarotto; Andreas K Buck; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-15       Impact factor: 9.236

5.  Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.

Authors:  M W Kattan; T M Wheeler; P T Scardino
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

6.  Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy.

Authors:  Patrick Berkovic; Gert De Meerleer; Louke Delrue; Bieke Lambert; Valérie Fonteyne; Nicolaas Lumen; Karel Decaestecker; Geert Villeirs; Philippe Vuye; Piet Ost
Journal:  Clin Genitourin Cancer       Date:  2012-09-24       Impact factor: 2.872

Review 7.  EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

Authors:  Axel Heidenreich; Patrick J Bastian; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Theodor van der Kwast; Malcolm Mason; Vsevolod Matveev; Thomas Wiegel; Filiberto Zattoni; Nicolas Mottet
Journal:  Eur Urol       Date:  2013-11-12       Impact factor: 20.096

8.  Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?

Authors:  Paolo Castellucci; Francesco Ceci; Tiziano Graziani; Riccardo Schiavina; Eugenio Brunocilla; Renzo Mazzarotto; Cinzia Pettinato; Monica Celli; Filippo Lodi; Stefano Fanti
Journal:  J Nucl Med       Date:  2014-06-16       Impact factor: 10.057

9.  Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.

Authors:  Nazareno Suardi; Giorgio Gandaglia; Andrea Gallina; Ettore Di Trapani; Vincenzo Scattoni; Damiano Vizziello; Vito Cucchiara; Roberto Bertini; Renzo Colombo; Maria Picchio; Giampiero Giovacchini; Francesco Montorsi; Alberto Briganti
Journal:  Eur Urol       Date:  2014-02-18       Impact factor: 20.096
  9 in total
  5 in total

1.  (11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series.

Authors:  Tiziano Graziani; Francesco Ceci; Paolo Castellucci; Giulia Polverari; Giacomo Maria Lima; Filippo Lodi; Alessio Giuseppe Morganti; Andrea Ardizzoni; Riccardo Schiavina; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-08       Impact factor: 9.236

2.  68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.

Authors:  Jeremie Calais; Johannes Czernin; Minsong Cao; Amar U Kishan; John V Hegde; Narek Shaverdian; Kiri Sandler; Fang-I Chu; Chris R King; Michael L Steinberg; Isabel Rauscher; Nina-Sophie Schmidt-Hegemann; Thorsten Poeppel; Philipp Hetkamp; Francesco Ceci; Ken Herrmann; Wolfgang P Fendler; Matthias Eiber; Nicholas G Nickols
Journal:  J Nucl Med       Date:  2017-11-09       Impact factor: 10.057

Review 3.  PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.

Authors:  Stefano Fanti; Silvia Minozzi; Paolo Castellucci; Sara Balduzzi; Ken Herrmann; Bernd Joachim Krause; Wim Oyen; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-09       Impact factor: 9.236

4.  Differential diagnosis of <3 cm renal tumors by ultrasonography: a rapid, quantitative, elastography self-corrected contrast-enhanced ultrasound imaging mode beyond screening.

Authors:  Di Sun; Qijie Lu; Cong Wei; Yi Li; Yuanyi Zheng; Bing Hu
Journal:  Br J Radiol       Date:  2020-06-09       Impact factor: 3.039

5.  Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment.

Authors:  Nina-Sophie Hegemann; Vera Wenter; Sonja Spath; Nadia Kusumo; Minglun Li; Peter Bartenstein; Wolfgang P Fendler; Christian Stief; Claus Belka; Ute Ganswindt
Journal:  Radiat Oncol       Date:  2016-03-11       Impact factor: 3.481
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.